About Us - Norwich Capital

Our Story

A Pioneer in Asia for listing Special Purpose Acquisition Companies (SPACs) in the U.S.

How Norwich Started

Opportunities beyond traditional IPOs

We are a pioneer in Asia for listing Special Purpose Acquisition Companies (SPACs) in the U.S.. SPACs are public listing vehicles that were first launched in the early 2000’s as alternatives to traditional IPOs. SPAC mergers combine the benefits of an IPO with the structural flexibility of M&A, providing target companies the certainty of closing, an accelerated go-public timeline, flexible transaction structure and instant world-class investor base opening up to greater liquidity and access to capital in the public markets.

Learn more about

United States SPAC

Hong Kong SPAC

What We Offer

Everything you need to get your company listed

Norwich offers comprehensive professional overseas listing-related services, including De-SPAC transactions and traditional IPOs

Building a Professional Team

As the main coordinator, we assist in assembling a teamof domestic and international professional service institutions necessary for the listing process

Establish Listing Structure

Assist in formulating and implementing a listing restructuring plan

Financial Review/Audit

Assist in coordinating the involvement of accountants

Legal/ Compliance

Provide specific remedial suggestions and assist in improving corporate governance structure

Development Strategy

Assist in formulating overall business objectives and development strategies, optimizing business model

Post-Business Combination Services

Assist in formulating and implementing investor relations management and market value management

Unsure where to begin?
Contact us —we're here to help!

OUR PORTFOLIO

Gain new perspective on our best listed company

View Our Portfolio

Our Management Team

The team brings together decades of experience across financial services, M&A and IPO experience

Jason Ma

Vice Chairman

Jason Ma is a seasoned veteran in the U.S. capital market, boasting over 15 years of experience in bringing Asian companies public in the U.S. through IPO, Reverse Merger, and SPAC transactions. Since 2017, he has specialized in SPAC business combinations, successfully spearheading approximately 10 SPAC IPOs and completing multiple De-SPACs. In 2018, he served as CEO and Chairman of Tottenham Acquisition I Limited, where he played a pivotal role in acquiring a U.S. pharmaceutical company focused on drug development for various neuro diseases. Jason's extensive expertise also includes leading advisory roles for SPACs in identifying and acquiring targets, as well as preparing targets for IPO readiness, regulatory approval, and capital raising efforts.

Eugene Wong

Managing Director

Eugene Wong is a distinguished professional with a robust background in business leadership and investment management. As the Chief Executive Officer of Ace Global Business Acquisition Limited (NASDAQ: ACBA) since 2021, he has overseen significant business combinations, including a notable agreement with LE Worldwide Limited. Since 2013, Eugene has been the Managing Director of Whiz Partners Asia Limited, a joint venture focusing on TMT, gaming, healthcare, and biotechnology investments, and facilitating business expansion for Japanese technology companies in China and Asia. Additionally, he is the Founding Partner and Chief Investment Officer of China Hero Project Fund, a game development fund in partnership with Sony Interactive Entertainment China. Eugene also serves as the Chief Strategy Officer for Cornwall Medical, a Hong Kong-based provider of high-intensity focused ultrasound (HIFU) treatment for women's health. His academic credentials include a Master of Business Administration from Tsinghua University and a Bachelor of Arts in Economics from the University of Chicago.

Norwich's Media Press Kit

Download

Full Profile
Photo Library
Media Coverage

A Pioneer in Asia for listing Special Purpose Acquisition Companies (SPACs) in the U.S.

Opportunities beyond traditional IPOs